Johnson & Johnson (JNJ) Tops Q2 EPS by 3c, FY Guidance Misses Views
Tweet
Share
E-mail
Get Alerts JNJ Hot Sheet
Price: $275.23 --0%
EPS Growth %: +3.6%
Financial Fact:
Other (income) expense, net: -54M
Today's EPS Names:
VIVO, BIOX, PMCB, More
EPS Growth %: +3.6%
Financial Fact:
Other (income) expense, net: -54M
Today's EPS Names:
VIVO, BIOX, PMCB, More
Join SI Premium – FREE
Johnson & Johnson (NYSE: JNJ) reported Q2 EPS of $2.10, $0.03 better than the analyst estimate of $2.07. Revenue for the quarter came in at $20.8 billion versus the consensus estimate of $20.39 billion.
GUIDANCE:
Johnson & Johnson sees FY2018 EPS of $8.07-$8.17, versus the consensus of $8.12. Johnson & Johnson sees FY2018 revenue of $80.5-81.3 billion, versus the consensus of $81.47 billion.
For earnings history and earnings-related data on Johnson & Johnson (JNJ) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- United Natural Foods (UNFI) Tops Q4 EPS by 8c ; Offers Guidance
- Hyperion DeFi raises FY26 guidance, launches $20M buyback
- Citi turns more bullish on trucking stocks
Create E-mail Alert Related Categories
Earnings, Guidance, Hot Earnings, Hot GuidanceRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
